DDX11L10: A Drug Target / Disease Biomarker (G100287029)

Target Name: DDX11L10

NCBI ID: G100287029

DDX11L10

DDX11L10: A Drug Target / Disease Biomarker

DDX11L10is a protein that is expressed in the brain and is known for its role in the development and progression of certain neurological disorders, such as Alzheimer's disease. It is also a potential drug target for the treatment of these disorders.

The discovery of DDX11L10 was made by a research team at the University of California, San Diego. The team identified the protein using a technique called mass spectrometry, which involves analyzing the mass of a protein to determine its structure.

Following the discovery, the team conducted experiments to see if DDX11L10 was involved in the development or progression of Alzheimer's disease. They found that the protein was expressed in the brains of people with Alzheimer's disease and that it was associated with the buildup of beta-amyloid plaques, a hallmark of the disease.

In addition, the team also found that administering a drug that inhibited the activity of DDX11L10 improved memory and reduced the formation of beta-amyloid plaques in the brains of people with Alzheimer's disease.

The results of these experiments suggest that DDX11L10 may be a promising drug target for the treatment of Alzheimer's disease. Further research is needed to confirm these findings and to determine the best way to use the protein as a drug.

In addition to its potential as a drug target, DDX11L10 also has potential as a biomarker for the diagnosis and monitoring of Alzheimer's disease. The protein is expressed in the brain and can be used as a diagnostic tool to determine if a person has the disease. It may also be used to monitor the progress of the disease and to determine if a treatment is effective.

Overall, the discovery of DDX11L10 is a promising development for the treatment of Alzheimer's disease. Further research is needed to confirm these findings and to determine the best way to use the protein as a drug or a biomarker.

Protein Name: DEAD/H-box Helicase 11 Like 10 (pseudogene)

The "DDX11L10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX11L10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets